BRIEF-CSPC Pharmaceutical Group's Gastric Cancer Drug Granted Orphan-Drug Designation By U.S. FDA
Feb 6 (Reuters) - CSPC Pharmaceutical Group Ltd:
* GROUP'S GASTRIC CANCER DRUG "DP303C" WAS GRANTED ORPHAN-DRUG DESIGNATION BY U.S. FDA Source text for Eikon: Further company coverage: